Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. As manufacturers prepare for launch, they must sort through and choose third-party organizations that can help support their efforts: 3PL organizations, distribution partners, pharmacies, HUB providers, serialization partners, data analytics, and more.
Getting answers to the eleven key questions covered in this webinar will help guide commercial teams in effectively launching specialty products.
Learning Objectives Covered in the Webinar:
Identify the types of third-party organizations that can help support your specialty drug launch
Understand the key considerations and composition of establishing third-party partnerships
Determine the difference between having greater access or greater control, and how that can impact the commercial success of your launch
Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. That's where Archbow's team of market access experts can help. Contact us today to get started.
Watch the webinar archive here.
Read the blog post on this topic here.
Related Blog Posts:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe reach their commercial goals with strategic and tactical approaches to distribution, pharmacy, and patient access. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn, Twitter or subscribing to this blog which you can do below.